Global

Veterinary Sciences Experts

Gerd Sutter


Veterinary Sciences
Friedrich Loeffler Institute
Germany

Biography

Gerd Sutter is the Full Professor and Chair for Virology at Institute for Infectious Diseases and Zoonoses,Department of Veterinary Sciences, Ludwig-Maximilians-Universität München. Curriculum vitae 1981-1988 Veterinary Medicine, LMU Munich 1988-1990 Dr. med. vet. Doctorate, LMU Munich 1990-1993 Postdoctoral fello w at the Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda MD, USA 1996 Specialist for Vet. Microbiology (board exam) 1999 Habilitation in Virology, LMU Munich 1994-2003 Research group leader, Institute of Molecular Virology, Helmholtz Zentrum München 2003-2009 Director and Professor, Division of Virology, Paul-Ehrlich-Institut, Langen 2009 Full Professor and Chair for Virology, Department of Veterinary Sciences, LMU Munich

Research Interest

Research interests Vaccine development with emphasis on vectorvaccines based on Modified Vaccinia virus Ankara(MVA).   Prevention of zoonotic and emerging virusinfections, e.g. avianinfluenza, MERS and WestNile fever, orthopoxvirus infections.   Mechanisms of (pox-) viral modulation of the hostimmune system including evasion of innate andadaptive responses to infection.  

Publications

  • Song F., Fux R., Provacia L., Volz A., Eickmann M., Becker S., Osterhaus A.D., Haagmans B.L., Sutter G. (2013). Middle East Respiratory Syndrome Coronavirus (MERS-CoV) spike protein delivered by Modified Vaccinia Virus Ankara (MVA) efficiently induces virus- neutralizing antibodies. J Virol , 87:11950-11954.

  • Kremer M., Suezer Y., Vo lz A., Frenz T., Majzoub M., Hanschmann K., Lehmann M.H., Kalinke U., Sutter G. (2012). Critical role of perforin- dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox. PLoS Pathog , 8:e1002557.

  • Sutter G. , Moss B. (1992): Nonreplicating vaccinia vector efficiently expresses recombinant genes. PNAS USA , 89, 10847-10851 (first description of recombinant vaccinia virus MVA).

Global Experts from Germany

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America